Hot Features
プレミアム
Vivoryon Therapeut (VVY)
EU
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-04-17 | Dr. Frank T. WeberMD, CEO, Chief Medical Officer & Executive Director | 150.00k | 0.00 | Open Market Derivative Acquisition | - | - | - |
| 2026-04-17 | Dr. Julia NeugebauerHead of Investor Relations & Communications, COO & Executive Board Member | 150.00k | 0.00 | Open Market Derivative Acquisition | - | - | - |
| 2026-04-17 | Dr. Michael SchaefferChief Business Officer & Executive Director | 75.00k | 0.00 | Open Market Derivative Acquisition | - | - | - |
| 2025-12-10 | Dr. Frank T. WeberMD, CEO, Chief Medical Officer & Executive Director | 30.60k | 64.51k | 買い | 2.11 | 230.15k | 15.33% |
| 2025-10-16 | Dr. Julia NeugebauerHead of Investor Relations & Communications, COO & Executive Board Member | 20.00k | 0.00 | Open Market Derivative Acquisition | - | - | - |
| 2025-06-30 | Dr. Erich M. PlatzerIndependent Non-Executive Chairman | 25.00k | 0.00 | Open Market Derivative Acquisition | - | - | - |
| 2025-06-30 | Ms. Charlotte LohmannIndependent Vice Chair of the Board | 25.00k | 0.00 | Open Market Derivative Acquisition | - | - | - |
| 2025-06-30 | Dr. Claudia RiedlIndependent Non-Executive Director | 25.00k | 0.00 | Open Market Derivative Acquisition | - | - | - |
| 2025-06-30 | Dr. Samir ShahIndependent Non-Executive Director | 25.00k | 0.00 | Open Market Derivative Acquisition | - | - | - |
| 2025-06-24 | Dr. Julia NeugebauerHead of Investor Relations & Communications, COO & Executive Board Member | 50.00k | 0.00 | Open Market Derivative Acquisition | - | - | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
